De novo autoimmune hepatitis after liver transplantation

Seminars in Liver Disease

Volumn 31, Issue 1, 2011, Pages 71-81

  Guido, Maria ^a   Burra, Patrizia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autoimmune hepatitis; histology; liver transplantation

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; GLUTATHIONE TRANSFERASE T1; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT; CASE REPORT; DE NOVO AUTOIMMUNE HEPATITIS; GRAFT DYSFUNCTION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INFLAMMATORY INFILTRATE; LIVER TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PLASMA CELL; PORTAL VEIN; PRIORITY JOURNAL;

GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RECURRENCE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79951865076     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1272834     Document Type: Article

References (86)

1. Kerkar N, Hadzi N, Davies E T. et al. De-novo autoimmune hepatitis after liver tran (Pubitemid 28064165)
2. Heneghan M A., Portmann B C., Norris S M. et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001 34 3 464-470 (Pubitemid 32791325)
3. Conti F, Dousset B, Levillayer H, Gruska I, Weill B, Calmus Y. Autoantibodies after liver transplantation: a marker of allograft disease. J Hepatol 1997 26 S1 150A
4. Jones D E., James O F., Portmann B, Burt A D., Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology 1999 30 1 53-57 (Pubitemid 29300568)
5. Andries S, Casamayou L, Sempoux C et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001 72 2 267-272 (Pubitemid 32729347)
6. Tan C K., Sian Ho J M. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl 2001 7 5 461-465 (Pubitemid 32492586)
7. Spada M, Bertani A, Sonzogni A et al. A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. Transplant Proc 2001 33 1-2 1747-1748 (Pubitemid 32238048)
8. Gupta P, Hart J, Millis J M., Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001 71 5 664-668 (Pubitemid 32268071)
9. Hernandez H M., Kovarik P, Whitington P F., Alonso E M. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001 32 2 131-136 (Pubitemid 32280624)
10. Yoshizawa K, Shirakawa H, Ichijo T et al. De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis. Clin Transplant 2008 22 3 385-390 (Pubitemid 351689672)
11. Oya H, Sato Y, Yamamoto S et al. De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report. Transplant Proc 2009 41 1 433-434
12. Berardi S, Lodato F, Gramenzi A et al. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut 2007 56 2 237-242
13. Rifle G, Mousson C, Martin L, Guignier F, Hajji K. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 2005 79 3, Suppl S14-S18 (Pubitemid 40293566)
14. Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004 40 1 3-7 (Pubitemid 38064706)
15. Hbscher S G. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome. Liver Transpl 2001 7 4 285-291
16. Jones DEJ, James OFW, Portmann B, Burt A D., Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology 1999 30 1 53-57 (Pubitemid 29300568)
17. Czaja A J. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002 8 6 505-513 (Pubitemid 34619081)
18. Vanderlugt C L., Miller S D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002 2 2 85-95 (Pubitemid 37323232)
19. Aichele P, Bachmann M F., Hengartner H, Zinkernagel R M. Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 1996 152 21-45 (Pubitemid 26362751)
20. Oldstone MBA. Molecular mimicry and immune-mediated diseases. FASEB J 1998 12 13 1255-1265 (Pubitemid 28475568)
21. Choudhuri K, Gregorio G V., Mieli-Vergani G, Vergani D. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis. Hepatology 1998 28 5 1177-1181 (Pubitemid 28493824)
22. Zhao Z S., Granucci F, Yeh L, Schaffer P A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998 279 5355 1344-1347 (Pubitemid 28119574)
23. Albert L J., Inman R D. Molecular mimicry and autoimmunity. N Engl J Med 1999 341 27 2068-2074 (Pubitemid 30035957)
24. Salcedo M, Vaquero J, Baares R et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology 2002 35 2 349-356 (Pubitemid 34106374)
25. Bucy R P., Xu X Y., Li J, Huang G Q. Cyclosporin A-induced autoimmune disease in mice. J Immunol 1993 151 2 1039-1050 (Pubitemid 23215769)
26. Glazier A, Tutschka P J., Farmer E R., Santos G W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983 158 1 1-8 (Pubitemid 13073506)
27. Hess A D., Fischer A C. Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease. Transplantation 1989 48 6 895-900 (Pubitemid 20018337)
28. Hess A D., Horwitz L R., Laulis M K. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo. Transplant Proc 1993 25 1 Pt 2 1218-1221 (Pubitemid 23078963)
29. Hess A D., Horwitz L R., Laulis M K., Fuchs E. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens. Clin Immunol Immunopathol 1993 69 3 341-350
30. Cooper M H., Hartman G G., Starzl T E., Fung J J. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc 1991 23 6 3234-3235
31. Cholongitas E, Samonakis D, Patch D et al. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. Transplantation 2006 81 3 488-490 (Pubitemid 43255742)
32. Kontorinis N, Agarwal K, Elhajj N, Fiel M I., Schiano T D. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006 12 5 827-830
33. Stanca C M., Fiel M I., Kontorinis N, Agarwal K, Emre S, Schiano T D. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation 2007 84 2 180-186 (Pubitemid 47205751)
34. Fiel M I., Agarwal K, Stanca C et al. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008 14 6 861-871 (Pubitemid 351895516)
35. Ward S C., Schiano T D., Thung S N., Fiel M I. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl 2009 15 12 1826-1833
36. Clifford B D., Donahue D, Smith L et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995 21 3 613-619
37. Muratori P, Muratori L, Stroffolini T et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol 2003 131 1 118-121 (Pubitemid 36098830)
38. Ferri S, Muratori L, Lenzi M, Granito A, Bianchi F B., Vergani D. HCV and autoimmunity. Curr Pharm Des 2008 14 17 1678-1685 (Pubitemid 351998592)
39. Garca-Buey L, Garca-Monzón C, Rodriguez S et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995 108 6 1770-1777
40. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein T I., Van Thiel D H. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepatogastroenterology 1997 44 14 417-425 (Pubitemid 27171051)
41. Noda K, Enomoto N, Arai K et al. Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy. Scand J Gastroenterol 1996 31 7 716-722 (Pubitemid 26290938)
42. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998 282 5390 938-941 (Pubitemid 28507525)
43. Stroffolini T, Colloredo G, Gaeta G B. et al. Does an autoimmune' profile affect the clinical profile of chronic hepatitis C An Italian multicentre survey. J Viral Hepat 2004 11 3 257-262 (Pubitemid 38658451)
44. Narciso-Schiavon J L., Freire F C., Suarez M M. et al. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon? Eur J Gastroenterol Hepatol 2009 21 4 440-446
45. Bianchi F B., Muratori P, Granito A, Pappas G, Ferri S, Muratori L. Hepatitis C and autoreactivity. Dig Liver Dis 2007 39 Suppl 1 S22-S24 (Pubitemid 47541921)
46. Czaja A J., Carpenter H A. Histological findings in chronic hepatitis C with autoimmune features. Hepatology 1997 26 2 459-466 (Pubitemid 27328326)
47. Chrtien P, Chousterman M, Abd Alsamad I et al. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun 2009 32 3-4 201-205
48. Khettry U, Huang W Y., Simpson M A. et al. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients. Hum Pathol 2007 38 3 443-452 (Pubitemid 46227528)
49. Czaja A J., Manns M P. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010 139 1 58-72, e4
50. Wiegard C, Schramm C, Lohse A W. Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis 2009 29 3 254-261
51. Demetris A J., Adeyi O, Bellamy C O. et al, Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006 44 2 489-501 (Pubitemid 44214890)
52. Bogdanos D P., Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 2009 29 3 241-253
53. Aguilera I, Wichmann I, Sousa J M. et al. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol 2001 126 3 535-539 (Pubitemid 34008729)
54. Aguilera I, Sousa J M., Gaviln F, Bernardos A, Wichmann I, Nuez-Roldn A. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 2004 10 9 1166-1172 (Pubitemid 39255364)
55. Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998 65 8 1072-1075 (Pubitemid 28208426)
56. Duclos-Valle J C., Johanet C, Bach J F., Yamamoto A M. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J Hepatol 2000 33 1 163-166 (Pubitemid 30418950)
57. Lohse A W., Obermayer-Straub P, Gerken G et al. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease possible association with a steroid-resistant transplant rejection episode. J Hepatol 1999 31 1 149-155 (Pubitemid 29287621)
58. Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998 65 8 1072-1075 (Pubitemid 28208426)
59. Duclos-Valle J C., Johanet C, Bach J F., Yamamoto A M. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J Hepatol 2000 33 1 163-166 (Pubitemid 30418950)
60. Shinkura N, Ikai I, Egawa H et al. Presence of anti-FKBP12 autoantibodies in patients with liver allografts: its association with allograft rejection. Transplantation 1997 64 9 1336-1342 (Pubitemid 27495969)
61. Salcedo M, Vaquero J, Banares R et al. Serum autoantibodies after liver transplantation. Prevalence and associated immunologic disorders. J Hepatol 2003 34 47A
62. Evans H M., Kelly D A., McKiernan P J., Hbscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006 43 5 1109-1117 (Pubitemid 43724635)
63. Avitzur Y, Ngan B Y., Lao M, Fecteau A, Ng V L. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation. J Pediatr Gastroenterol Nutr 2007 45 2 222-227 (Pubitemid 47220531)
64. Richter A, Grabhorn E, Helmke K, Manns M P., Ganschow R, Burdelski M. Clinical relevance of autoantibodies after pediatric liver transplantation. Clin Transplant 2007 21 3 427-432 (Pubitemid 46711410)
65. Riva S, Sonzogni A, Bravi M et al. Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl 2006 12 4 573-577
66. Hadzic N, Srinivasan R, Rela M et al. De novo autoimmune hepatitis after liver transplantation in children; a single centre experience. Hepatology 2003 38 202A
67. Bogdanos D P., Invernizzi P, Mackay I R., Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008 14 21 3374-3387
68. Bach N, Thung S N., Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992 15 4 572-577
69. Czaja A J., Carpenter H A. Autoimmune Hepatitis. In: McSween R NM Burt A D. Portmann B C. Ishak K I. Scheuer P J. Anthony P P. eds. Pathology of the Liver. London Churchill Livingstone 2002 415-434
70. Hennes E M., Zeniya M, Czaja A J. et al, International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008 48 1 169-176 (Pubitemid 351975541)
71. Misdraji J, Thiim M, Graeme-Cook F M. Autoimmune hepatitis with centrilobular necrosis. Am J Surg Pathol 2004 28 4 471-478 (Pubitemid 38436520)
72. Hofer H, Oesterreicher C, Wrba F, Ferenci P, Penner E. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006 59 3 246-249 (Pubitemid 43344883)
73. Zen Y, Notsumata K, Tanaka N, Nakanuma Y. Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? Hum Pathol 2007 38 11 1669-1675 (Pubitemid 47589090)
74. Demetris A J., Crawford J M., Minervini M I. et al. Transplantation pathology of the liver. In: Odze R D. Goldblum J R. eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. 2nd ed. Philadelphia Saunders/Elsevier 2009 1177-1180
75. Hubscher S GPB. Transplantation pathology. In: MacSween R NM Burt A D. Ferrell L D. eds. Pathology of the Liver. 5th ed. London Churchill Livingstone 2007 815-879
76. Adeyi O, Fischer S E., Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation. J Clin Pathol 2010 63 1 47-74
77. Czaja A J., Carpenter H A. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001 34 4 Pt 1 659-665 (Pubitemid 32927988)
78. Krasinskas A M., Ruchelli E D., Rand E B., Chittams J L., Furth E E. Central venulitis in pediatric liver allografts. Hepatology 2001 33 5 1141-1147 (Pubitemid 32378213)
79. Nakazawa Y, Walker N I., Kerlin P et al. Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients. Transplantation 2000 69 8 1599-1608
80. Tsamandas A C., Jain A B., Felekouras E S., Fung J J., Demetris A J., Lee R G. Central venulitis in the allograft liver: a clinicopathologic study. Transplantation 1997 64 2 252-257 (Pubitemid 27332668)
81. Ludwig J, Gross J B. Jr, Perkins J D., Moore S B. Persistent centrilobular necroses in hepatic allografts. Hum Pathol 1990 21 6 656-661 (Pubitemid 20204955)
82. Turlin B, Slapak G I., Hayllar K M., Heaton N, Williams R, Portmann B. Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl Surg 1995 1 5 285-289
83. Demetris A J. Central venulitis in liver allografts: considerations of differential diagnosis. Hepatology 2001 33 5 1329-1330 (Pubitemid 32378234)
84. Demetris A J., Eghtesad B, Marcos A et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004 28 5 658-669 (Pubitemid 38579570)
85. Ziarkiewicz-Wróblewska B, Wróblewski T, Wasiutyski A. Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation - literature review and results of single transplantation center. Ann Transplant 2008 13 2 12-20
86. Manns M P., Czaja A J., Gorham J D. et al, American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 2010 51 6 2193-2213